Related Experiment Video
Updated: Aug 7, 2025

07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
7.2K
Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE.
Matthew Roberts1,2, Julia Ogden2,3, A S Mukarram Hossain1,2
1Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Macclesfield, United Kingdom.
Elife
|March 9, 2023
Summary
Researchers developed XTABLE, an application integrating transcriptomic data from lung squamous cell carcinoma (LUSC) premalignant lesions (PMLs). This tool aids in discovering early detection biomarkers and understanding LUSC progression.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Lung squamous cell carcinoma (LUSC) has a poor prognosis and limited therapeutic options.
- Understanding premalignant lesions (PMLs) in LUSC is crucial for early detection and prevention.
- Identifying molecular drivers of malignant progression in LUSC is a key research challenge.
Purpose of the Study:
- To develop an open-source application, XTABLE, for analyzing transcriptomic data of LUSC PMLs.
- To facilitate research into the biology of LUSC PMLs and identify early detection biomarkers.
- To investigate the role of chromosomal instability and map LUSC pathways during disease progression.
Main Methods:
- Designed XTABLE, an application integrating extensive transcriptomic databases of LUSC PMLs.
- Enabled users to stratify samples and perform various biological interrogations (e.g., group comparisons, gene analysis).
- Conducted a comparative study on chromosomal instability scores and mapped LUSC pathways to PML developmental stages.
Main Results:
- XTABLE provides a comprehensive platform for exploring LUSC PML transcriptomes.
- Chromosomal instability scores were evaluated as potential biomarkers for PML progression.
- Key LUSC pathways were mapped to specific stages of LUSC development.
Conclusions:
- XTABLE significantly facilitates research on LUSC early detection biomarkers.
- The application enhances understanding of the molecular processes underlying LUSC precancerous stages.
- Further research using XTABLE can improve LUSC prevention and treatment strategies.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K

